Vaccines for a 79-Year-Old Male
For a 79-year-old male, you must ask about annual influenza vaccination, pneumococcal vaccination (both PCV and PPSV23), recombinant zoster vaccine (RZV), tetanus-diphtheria-pertussis (Tdap/Td) booster, and COVID-19 vaccination status. 1, 2
Core Routine Vaccinations by Age
Influenza (Annual)
- Administer annually with inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV) 1
- For patients ≥65 years, high-dose IIV3 (HD-IIV3) or adjuvanted IIV3 (aIIV3) are preferentially recommended over standard-dose vaccines 2
- This is a critical annual intervention that reduces morbidity and mortality in older adults 3
Pneumococcal Vaccination
This is where most clinicians miss opportunities. The 2025 guidelines now recommend:
- All adults ≥50 years should receive pneumococcal conjugate vaccine (PCV15, PCV20, or PCV21) if never previously vaccinated with any PCV 2
- For your 79-year-old patient:
Recombinant Zoster Vaccine (RZV/Shingrix)
- 2-dose series (RZV preferred) for all adults ≥50 years, given 2-6 months apart 1, 2
- At 79 years old, this patient should have received this already
- RZV is far superior to the older live zoster vaccine (ZVL) which is no longer preferred 1
- Even with prior shingles history, vaccination is still recommended 5
Tetanus-Diphtheria-Pertussis (Tdap/Td)
- One dose of Tdap if never received as an adult, then Td or Tdap booster every 10 years 1
- Most adults born before 1957 likely need assessment of their last tetanus booster
- Tdap has higher rates of local reactions but provides pertussis protection 6
COVID-19
- Adults ≥65 years: 2 or more doses of updated 2024-2025 vaccine 2
- This is now part of routine adult immunization schedules
- Frequency and formulation updates occur annually, similar to influenza
Additional Vaccines Based on Risk Factors
Hepatitis B
Ask about:
- Chronic liver disease, end-stage renal disease, diabetes, or HIV infection
- If any of these apply: 2-3 dose series depending on vaccine formulation 1, 7
Hepatitis A
Ask about:
- Chronic liver disease, travel to endemic areas, men who have sex with men
- If indicated: 2-dose series 1, 7
RSV (Respiratory Syncytial Virus)
- All adults ≥75 years: 1 dose if not previously vaccinated 2
- For ages 60-74: Only if risk factors for severe RSV disease 2
- Your 79-year-old patient qualifies for universal RSV vaccination
Common Pitfalls to Avoid
Don't assume birth before 1957 means MMR immunity is adequate - this only applies to measles/mumps, not rubella, and doesn't apply to healthcare workers 5
Don't give PPSV23 alone to a patient who has never received PCV - the 2019 ACIP update changed this, making PCV13 (now PCV15/20/21) the priority 1, 2
Don't forget to ask about the last tetanus booster - many older adults are overdue and at risk for tetanus, which has high mortality in the elderly 1
Don't skip zoster vaccine because the patient had shingles - prior disease doesn't confer complete immunity 5
Don't use live attenuated influenza vaccine (LAIV) in patients ≥50 years - only inactivated or recombinant formulations 1
Practical Assessment Algorithm
Ask these specific questions:
- "When was your last flu shot?" → If >1 year or unknown: Give now
- "Have you had the pneumonia vaccines - both the newer one (Prevnar) and the older one (Pneumovax)?" → If uncertain or incomplete: Review records and complete series
- "Have you had the shingles vaccine - the newer two-shot series called Shingrix?" → If no or only old Zostavax: Give RZV 2-dose series
- "When was your last tetanus shot?" → If >10 years or unknown: Give Tdap
- "Are you up to date with COVID vaccines?" → Give updated 2024-2025 formulation
- "Have you had the RSV vaccine?" → If no: Give 1 dose (he's ≥75 years) 2
Then assess risk-based vaccines:
- Chronic liver disease, diabetes, renal disease? → Hepatitis B series
- Travel plans, chronic liver disease? → Hepatitis A series
The 2025 ACIP guidelines 2 represent the most current recommendations and show a trend toward earlier pneumococcal vaccination (now starting at age 50) and universal RSV vaccination for those ≥75 years, reflecting the significant disease burden in older adults.